pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-640 |
Genomic Coordinates | chr19: 19435063 - 19435158 |
Synonyms | MIRN640, hsa-mir-640, MIR640 |
Description | Homo sapiens miR-640 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-640 | |||||||||||||||||||||
Sequence | 61| AUGAUCCAGGAACCUGCCUCU |81 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | RT-PCR | DRVs in miRNA |
|
|||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MOB4 | ||||||||||||||||||||
Synonyms | 2C4D, CGI-95, MOB1, MOB3, MOBKL3, PHOCN, PREI3 | ||||||||||||||||||||
Description | MOB family member 4, phocein | ||||||||||||||||||||
Transcript | NM_001100819 | ||||||||||||||||||||
Other Transcripts | NM_015387 , NM_199482 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MOB4 | |||||||||||||||||||||
3'UTR of MOB4 (miRNA target sites are highlighted) |
>MOB4|NM_001100819|3'UTR 1 AGGGAATCATAGGAAAAATGTACTGATCATATAATTAACATTATGTACTGTATATATCATTTTAGACACATCAATCATGT 81 ATCCATATTATAGCTTCTTTGTTTAGTATAGGTTTTTGTATGCTGGGTTTGCCTTTTAAAATGGGAAATACTTTTTAAGT 161 TATTCATAAGCTGTATATTCACCAGTGTGGCACTCATGGTTTTTAAATAAGATTAGTATTATCTGTTTATAATGCCTGTT 241 AATAAAAGAATTTACAGTTTGGTAAAATTGCTGCTAAACAATCATTGGATCACAATCCTCATCAGACAAACCCATCTGTA 321 AAAAAAATGAGGGAGAGCTTGAGGTTTCACACAAGCCATTTACTAAAGAGGTAGAAATGTTTTCTATTGGTTTTACCTTG 401 AGTTTAGATATCCTAAAAAATTCTGTAGTACGTAGTTTTGTCTTACCTGTTAACTTTCCCCAATTGAGATAAAAGTGTTT 481 TAAAATTCTGTTTATAGTTTTTGATATGCATATATAATTATGTGTATATCTAAATACAAATGCAAATGAAGCATTAGTAA 561 TACTTAAATAATTTTACTGTGCTACATAAAGTATAACATACTTGGAAAGGATTTACCGTTCTGCAACAACGGACTGGTAC 641 ATACAGGATGATCACAATGGTAAGGCACATAAATTATTTTCCCACTGGAAACCTGCCCTGTCCACCCCTTCTCATTTCCC 721 TTAACCTTATCTTCAAACTACTTTAGCTGAGAAGCTTTTCACCAGACTGAGTTAGTGGTGGCTTATACCTATTTATATTT 801 GTATTAATTGCTTACAGATTATACCTCATATTAGCAATTACATTACACTACAAGAAAATGTATTTGCATAGGCTCTTGCT 881 TATCTTTGTTTTGCAAAATTGTTCTACTTAGAAAACAGTCCTTAAAATAGTTTGACTCTTCCTGTTAGTAATATATTAAT 961 CTTTCATTTAACCAGCTAGGCAGCATTAAATAGAATTGAAGAAATACCATAGTATTTATTTTACACCCCCTCTCCCACGA 1041 AGTTTATGTTTGGATTACATGCACGTGTGAGATTATTTGCAATAATTCATAGGTTCCAAGGGTGTTGATGAATAGTCATA 1121 CATTTTTTTGGACTTTGTTATAATTCATTGTGGTAAGAATGATTGAAATGCAGATTTAACAATCTTATAATCTATTGAAT 1201 GCCATTTTTGATAAAGCACTGGAGGTCTTATTGCCAAACTGATTGTAATGAGGCAGTAAGGGTGAAAACATTGTACATGT 1281 TGTGAAGAAAGTATTTAAATCCAACTTTTGAACAGATTTAACAAACATGAGGAACTTTTTTATTTAGAAGGATAATTTTG 1361 AAGATGAAAATGTATTCATCTTAATTGTTTTTTCAAATTTAAGGGAATAATTTATACCATCTTTTCAGACAAGAATGTAC 1441 AGCAAAAATAAGGGGAACAGTAGTATACTGAGAGTGTGTGTATGTATAGTGTATGCCTTTCCAAGCTTGCCAGTCTTTTT 1521 GGCTTTGAACACTGCCCATCAGCTACAGTCATTACTGTTCCCCAACCCACAACTATCTTTTAAGAAGTCTTAGTTCACAG 1601 TGAAAGGAATGATGACTTTGAAATTATGGATTTATATTAATGGCACTATAAACCAATGGTAATGGTAATTTTTAAACTTG 1681 CTAAATATTGAGAAACTAAACTACTAAGTTAATAAATTATATATAGCAGTGTAGCTGTTCTCTCTAGATGGTGTCTCACA 1761 ATGGATTTCTGTTGCTTGACTATTTTCTTAGTGAATATTTATACTAAGGTAGTGACTGAGATTTGGTGATCTGGCTGAGT 1841 ATTTTGAAACACATTTTGAATAATATGGCTTAGTGTTAACGGGGACTTAAATATGATTTTTTTTTCTTACTCATTTCACC 1921 TTCCCTGTACTGTATGTTTGGAATTGATCATAAAACATCTCCAAAAGAAAATAATCAGTTTGTAGTCTTGCTTTTGTATT 2001 CATGTTGATAATCTTACTAATTGTGAAGTTGATTCACTACTATACTAGGTAAGACCTAAGTGAAACAGTTCCTGTTTTTC 2081 CTTAATACTGTTTTCAGAATTTTGAAAATGTACTTATATATACATAAATACTACTAAAAAATTAATGAGCCTGGCAAACC 2161 ATTGATTTATAAAAGTAAGTGTTCTAAGAGGGGAACAAGACAGTTCTGTGTGATAAGGAAGTTAGGCTCCACTTTTTGTT 2241 TGAATTACCCTATGTATATCCGAAGGTAAACTTAGGCTTTTCTTTCCAAAAGATCGTATAGTCAATTCATTCTTTTTCTC 2321 CTATCACATCTGGGAAAGTAGCTAACTTTTAACTATTTATGTTCCCATAAGTAACCCTTCTTTTGTGTGTATACATTTCC 2401 TTTTCTCTGACTTGAGATGTCAAATTTGGATTTCTAGAACAGTTTCTCAGTTAAATTCTTGATGACTTAACAACTTTTAC 2481 TATCAGAATACAATTAGAAATCCTTGGTCAGGCACAGGGGCTCACGCCTGTAATCCCAGCACTTTGGGAAGCCAAGGCAG 2561 ACAGATCACCTGAGGTCAGGAGTTCGAGACCAGCCTGACCAACATGGAGAAACCCTGTCTCTACTAAAAATACAAAAATT 2641 AGCCGGGCGTGGTGCTACTCGTGAGGCTGAGGCAGGAGAATCGCTTGAACCCGGGAGGTGGAGGTTGCGGTGAGCTGAGA 2721 TCGTGCCATTGCACTCCAGCCTGGGTAACGAGCAAAACTCCGTCTCAAAAACTCCGTCTCAAAAAAAAAAAATCCTTGAT 2801 TACATTGTTAGTAAGGACTGTGTTACGATTATAAACACATTTATTGGTTGATGTCAAATTCACTGTAATAGTAGAACTAA 2881 GTTTTTTATGTGAGTACTTTGCCCTACTGTCTATATGATGACATCTTTTTTGAGCAGCTAAATTTTAAATTGTATATACT 2961 TTATTTTGTGAATCCTTGTTGAATGTGCTAAAGGTTTCTTTGTGTAGTTCTTCCATGCTATGCGAATATTTTAGTAAAAG 3041 TAGTTGATTTTTAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 25843.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 25843.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000233892.4 | 3UTR | UAAAAUUGCUGCUAAACAAUCAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000233892.4 | 3UTR | UAAAAUUGCUGCUAAACAAUCAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000233892.4 | 3UTR | UAAAAUUGCUGCUAAACAAUCAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000233892.4 | 3UTR | UAAAAUUGCUGCUAAACAAUCAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000233892.4 | 3UTR | UAAAAUUGCUGCUAAACAAUCAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000233892.4 | 3UTR | UAAAAUUGCUGCUAAACAAUCAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
194 hsa-miR-640 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT097121 | TNPO1 | transportin 1 | 2 | 2 | ||||||||
MIRT115090 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 4 | ||||||||
MIRT204603 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 8 | ||||||||
MIRT204634 | MOB4 | MOB family member 4, phocein | 2 | 8 | ||||||||
MIRT344451 | MTRNR2L1 | MT-RNR2-like 1 | 2 | 2 | ||||||||
MIRT405772 | EIF5 | eukaryotic translation initiation factor 5 | 2 | 2 | ||||||||
MIRT445876 | SENP6 | SUMO1/sentrin specific peptidase 6 | 2 | 2 | ||||||||
MIRT497418 | FAM46A | family with sequence similarity 46 member A | 2 | 2 | ||||||||
MIRT504394 | HMX2 | H6 family homeobox 2 | 2 | 4 | ||||||||
MIRT504691 | SLCO2B1 | solute carrier organic anion transporter family member 2B1 | 2 | 8 | ||||||||
MIRT512386 | MTRNR2L3 | MT-RNR2-like 3 | 2 | 6 | ||||||||
MIRT513003 | MAN1A2 | mannosidase alpha class 1A member 2 | 2 | 2 | ||||||||
MIRT513084 | USP9X | ubiquitin specific peptidase 9, X-linked | 2 | 2 | ||||||||
MIRT519122 | ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) | 2 | 2 | ||||||||
MIRT523836 | F2RL1 | F2R like trypsin receptor 1 | 2 | 2 | ||||||||
MIRT565356 | TMCC1 | transmembrane and coiled-coil domain family 1 | 2 | 2 | ||||||||
MIRT575895 | Dis3 | DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease | 2 | 3 | ||||||||
MIRT576894 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT613780 | RPS6 | ribosomal protein S6 | 2 | 2 | ||||||||
MIRT613934 | POLR3A | RNA polymerase III subunit A | 2 | 2 | ||||||||
MIRT614348 | LOH12CR1 | BLOC-1 related complex subunit 5 | 2 | 2 | ||||||||
MIRT614534 | NOA1 | nitric oxide associated 1 | 2 | 2 | ||||||||
MIRT617019 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT618247 | MANEAL | mannosidase endo-alpha like | 2 | 2 | ||||||||
MIRT619051 | TTC4 | tetratricopeptide repeat domain 4 | 2 | 2 | ||||||||
MIRT619442 | ZNF517 | zinc finger protein 517 | 2 | 2 | ||||||||
MIRT619723 | FPR2 | formyl peptide receptor 2 | 2 | 2 | ||||||||
MIRT620179 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT620370 | ANKRD62 | ankyrin repeat domain 62 | 2 | 2 | ||||||||
MIRT621263 | RTN2 | reticulon 2 | 2 | 2 | ||||||||
MIRT621463 | APOH | apolipoprotein H | 2 | 2 | ||||||||
MIRT621571 | ZBTB43 | zinc finger and BTB domain containing 43 | 2 | 2 | ||||||||
MIRT621683 | TSPYL1 | TSPY like 1 | 2 | 2 | ||||||||
MIRT622866 | PDE7A | phosphodiesterase 7A | 2 | 2 | ||||||||
MIRT624669 | ARHGEF39 | Rho guanine nucleotide exchange factor 39 | 2 | 2 | ||||||||
MIRT625607 | ZNF84 | zinc finger protein 84 | 2 | 2 | ||||||||
MIRT626111 | IL23R | interleukin 23 receptor | 2 | 2 | ||||||||
MIRT628380 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT628553 | MELK | maternal embryonic leucine zipper kinase | 2 | 2 | ||||||||
MIRT628671 | C2orf72 | chromosome 2 open reading frame 72 | 2 | 2 | ||||||||
MIRT628747 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT628776 | TMEM154 | transmembrane protein 154 | 2 | 2 | ||||||||
MIRT628918 | ZNF430 | zinc finger protein 430 | 2 | 2 | ||||||||
MIRT629174 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT629209 | C12orf66 | chromosome 12 open reading frame 66 | 2 | 2 | ||||||||
MIRT629267 | SLC5A8 | solute carrier family 5 member 8 | 2 | 2 | ||||||||
MIRT629498 | AS3MT | arsenite methyltransferase | 2 | 2 | ||||||||
MIRT629665 | USP1 | ubiquitin specific peptidase 1 | 2 | 2 | ||||||||
MIRT629760 | STK25 | serine/threonine kinase 25 | 2 | 2 | ||||||||
MIRT630899 | GATAD1 | GATA zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT631105 | SLC15A2 | solute carrier family 15 member 2 | 2 | 2 | ||||||||
MIRT631112 | ATCAY | ATCAY, caytaxin | 2 | 2 | ||||||||
MIRT631450 | DLEU1 | deleted in lymphocytic leukemia 1 (non-protein coding) | 2 | 2 | ||||||||
MIRT631505 | FFAR4 | free fatty acid receptor 4 | 2 | 2 | ||||||||
MIRT631580 | ITGAL | integrin subunit alpha L | 2 | 2 | ||||||||
MIRT631836 | CMBL | carboxymethylenebutenolidase homolog | 2 | 2 | ||||||||
MIRT632342 | SWSAP1 | SWIM-type zinc finger 7 associated protein 1 | 2 | 2 | ||||||||
MIRT633214 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT633223 | ZNF43 | zinc finger protein 43 | 2 | 2 | ||||||||
MIRT633480 | ARIH2OS | ariadne RBR E3 ubiquitin protein ligase 2 opposite strand | 2 | 2 | ||||||||
MIRT633511 | LRRC27 | leucine rich repeat containing 27 | 2 | 2 | ||||||||
MIRT633615 | CWF19L1 | CWF19 like 1, cell cycle control (S. pombe) | 2 | 2 | ||||||||
MIRT633652 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT633677 | ZNF576 | zinc finger protein 576 | 2 | 2 | ||||||||
MIRT634196 | TMOD2 | tropomodulin 2 | 2 | 4 | ||||||||
MIRT634388 | PLSCR1 | phospholipid scramblase 1 | 2 | 2 | ||||||||
MIRT635817 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | 2 | 2 | ||||||||
MIRT635962 | TTC31 | tetratricopeptide repeat domain 31 | 2 | 2 | ||||||||
MIRT636114 | YPEL1 | yippee like 1 | 2 | 2 | ||||||||
MIRT636164 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT636768 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT637092 | CXorf23 | BCLAF1 and THRAP3 family member 3 | 2 | 2 | ||||||||
MIRT637316 | FAM9B | family with sequence similarity 9 member B | 2 | 2 | ||||||||
MIRT637540 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT637628 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT637826 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT637945 | IVD | isovaleryl-CoA dehydrogenase | 2 | 2 | ||||||||
MIRT637968 | IRF1 | interferon regulatory factor 1 | 2 | 2 | ||||||||
MIRT638321 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT638386 | RAB11FIP1 | RAB11 family interacting protein 1 | 2 | 2 | ||||||||
MIRT639244 | CRK | CRK proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT642608 | APOPT1 | apoptogenic 1, mitochondrial | 2 | 2 | ||||||||
MIRT642793 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT643847 | LACTB | lactamase beta | 2 | 4 | ||||||||
MIRT644705 | ZNF321P | zinc finger protein 321, pseudogene | 2 | 2 | ||||||||
MIRT645148 | DIS3 | DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease | 2 | 3 | ||||||||
MIRT646671 | CCDC69 | coiled-coil domain containing 69 | 2 | 2 | ||||||||
MIRT647780 | ASB8 | ankyrin repeat and SOCS box containing 8 | 2 | 2 | ||||||||
MIRT648554 | WDR92 | WD repeat domain 92 | 2 | 2 | ||||||||
MIRT648990 | MRPL49 | mitochondrial ribosomal protein L49 | 2 | 2 | ||||||||
MIRT649099 | KCNMB1 | potassium calcium-activated channel subfamily M regulatory beta subunit 1 | 2 | 2 | ||||||||
MIRT650141 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT650791 | GSR | glutathione-disulfide reductase | 2 | 2 | ||||||||
MIRT654967 | PLEKHA2 | pleckstrin homology domain containing A2 | 2 | 2 | ||||||||
MIRT655099 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT655516 | PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | 2 | 2 | ||||||||
MIRT656289 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT656497 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 2 | ||||||||
MIRT657074 | JPH2 | junctophilin 2 | 2 | 2 | ||||||||
MIRT657314 | HOOK3 | hook microtubule tethering protein 3 | 2 | 2 | ||||||||
MIRT657419 | HIF1AN | hypoxia inducible factor 1 alpha subunit inhibitor | 2 | 4 | ||||||||
MIRT659032 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 2 | 2 | ||||||||
MIRT659535 | CHCHD5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | 2 | 2 | ||||||||
MIRT661532 | NWD1 | NACHT and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT662029 | FUT2 | fucosyltransferase 2 | 2 | 2 | ||||||||
MIRT663206 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT663357 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT663557 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT663650 | POLM | DNA polymerase mu | 2 | 2 | ||||||||
MIRT663694 | ABHD17B | abhydrolase domain containing 17B | 2 | 2 | ||||||||
MIRT664370 | CYB5A | cytochrome b5 type A | 2 | 2 | ||||||||
MIRT664783 | LIAS | lipoic acid synthetase | 2 | 4 | ||||||||
MIRT665561 | TXNL1 | thioredoxin like 1 | 2 | 2 | ||||||||
MIRT665950 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT667338 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | 2 | 2 | ||||||||
MIRT667804 | ITIH5 | inter-alpha-trypsin inhibitor heavy chain family member 5 | 2 | 2 | ||||||||
MIRT668804 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT669470 | ARPC2 | actin related protein 2/3 complex subunit 2 | 2 | 2 | ||||||||
MIRT669599 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT669806 | STOML1 | stomatin like 1 | 2 | 2 | ||||||||
MIRT669944 | FBXL2 | F-box and leucine rich repeat protein 2 | 2 | 2 | ||||||||
MIRT670292 | RBBP4 | RB binding protein 4, chromatin remodeling factor | 2 | 2 | ||||||||
MIRT670381 | EMP2 | epithelial membrane protein 2 | 2 | 2 | ||||||||
MIRT670481 | DCUN1D2 | defective in cullin neddylation 1 domain containing 2 | 2 | 2 | ||||||||
MIRT670531 | KIF1C | kinesin family member 1C | 2 | 4 | ||||||||
MIRT670565 | GLTP | glycolipid transfer protein | 2 | 2 | ||||||||
MIRT670603 | NPHP1 | nephrocystin 1 | 2 | 2 | ||||||||
MIRT670880 | CYTIP | cytohesin 1 interacting protein | 2 | 2 | ||||||||
MIRT670931 | LIPG | lipase G, endothelial type | 2 | 2 | ||||||||
MIRT671261 | MTRNR2L5 | MT-RNR2-like 5 | 2 | 2 | ||||||||
MIRT671794 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT671897 | GBP4 | guanylate binding protein 4 | 2 | 2 | ||||||||
MIRT672000 | SLC35F6 | solute carrier family 35 member F6 | 2 | 4 | ||||||||
MIRT672074 | KIR3DX1 | killer cell immunoglobulin like receptor, three Ig domains X1 | 2 | 2 | ||||||||
MIRT672319 | C9orf3 | chromosome 9 open reading frame 3 | 2 | 2 | ||||||||
MIRT672853 | C22orf29 | retrotransposon Gag like 10 | 2 | 2 | ||||||||
MIRT673395 | WNT7B | Wnt family member 7B | 2 | 2 | ||||||||
MIRT673537 | DEGS1 | delta 4-desaturase, sphingolipid 1 | 2 | 2 | ||||||||
MIRT674285 | ZNF724P | zinc finger protein 724 | 2 | 2 | ||||||||
MIRT674494 | TIRAP | TIR domain containing adaptor protein | 2 | 2 | ||||||||
MIRT675460 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675569 | TRIP11 | thyroid hormone receptor interactor 11 | 2 | 2 | ||||||||
MIRT676068 | TIMM50 | translocase of inner mitochondrial membrane 50 | 2 | 2 | ||||||||
MIRT676254 | PBOV1 | prostate and breast cancer overexpressed 1 | 2 | 2 | ||||||||
MIRT676377 | SEC24D | SEC24 homolog D, COPII coat complex component | 2 | 2 | ||||||||
MIRT676758 | SNX2 | sorting nexin 2 | 2 | 2 | ||||||||
MIRT676773 | NPHS1 | NPHS1, nephrin | 2 | 2 | ||||||||
MIRT676874 | ENSA | endosulfine alpha | 2 | 2 | ||||||||
MIRT676918 | KLHDC8A | kelch domain containing 8A | 2 | 2 | ||||||||
MIRT676944 | S1PR3 | sphingosine-1-phosphate receptor 3 | 2 | 2 | ||||||||
MIRT676957 | HFE | hemochromatosis | 2 | 2 | ||||||||
MIRT676967 | RNF19B | ring finger protein 19B | 2 | 2 | ||||||||
MIRT676972 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT677042 | ZNF34 | zinc finger protein 34 | 2 | 2 | ||||||||
MIRT677070 | VMAC | vimentin type intermediate filament associated coiled-coil protein | 2 | 2 | ||||||||
MIRT677093 | MFSD11 | major facilitator superfamily domain containing 11 | 2 | 4 | ||||||||
MIRT677134 | P2RX7 | purinergic receptor P2X 7 | 2 | 2 | ||||||||
MIRT677179 | ZNF786 | zinc finger protein 786 | 2 | 2 | ||||||||
MIRT677228 | C15orf40 | chromosome 15 open reading frame 40 | 2 | 2 | ||||||||
MIRT677320 | PIGO | phosphatidylinositol glycan anchor biosynthesis class O | 2 | 2 | ||||||||
MIRT677455 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT677809 | MRPS10 | mitochondrial ribosomal protein S10 | 2 | 2 | ||||||||
MIRT677937 | ZNF519 | zinc finger protein 519 | 2 | 2 | ||||||||
MIRT678063 | UBN2 | ubinuclein 2 | 2 | 4 | ||||||||
MIRT678072 | EIF2A | eukaryotic translation initiation factor 2A | 2 | 2 | ||||||||
MIRT678252 | FXN | frataxin | 2 | 2 | ||||||||
MIRT678315 | FBLIM1 | filamin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT678367 | XIAP | X-linked inhibitor of apoptosis | 2 | 4 | ||||||||
MIRT678372 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT678410 | ANKRD36 | ankyrin repeat domain 36 | 2 | 2 | ||||||||
MIRT678518 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT678566 | CDK4 | cyclin dependent kinase 4 | 2 | 2 | ||||||||
MIRT678580 | PPP1R3B | protein phosphatase 1 regulatory subunit 3B | 2 | 2 | ||||||||
MIRT678820 | PDE6A | phosphodiesterase 6A | 2 | 2 | ||||||||
MIRT678917 | XPOT | exportin for tRNA | 2 | 2 | ||||||||
MIRT679217 | MAN2A2 | mannosidase alpha class 2A member 2 | 2 | 2 | ||||||||
MIRT679437 | C19orf52 | translocase of inner mitochondrial membrane 29 | 2 | 2 | ||||||||
MIRT679595 | HILPDA | hypoxia inducible lipid droplet associated | 2 | 2 | ||||||||
MIRT679755 | TLR6 | toll like receptor 6 | 2 | 2 | ||||||||
MIRT679800 | APOBEC3A | apolipoprotein B mRNA editing enzyme catalytic subunit 3A | 2 | 2 | ||||||||
MIRT680057 | CD96 | CD96 molecule | 2 | 2 | ||||||||
MIRT680116 | CCDC30 | coiled-coil domain containing 30 | 2 | 4 | ||||||||
MIRT680181 | ZNF554 | zinc finger protein 554 | 2 | 2 | ||||||||
MIRT680439 | WDR12 | WD repeat domain 12 | 2 | 2 | ||||||||
MIRT680789 | ZNF578 | zinc finger protein 578 | 2 | 2 | ||||||||
MIRT692464 | APEX2 | apurinic/apyrimidinic endodeoxyribonuclease 2 | 2 | 2 | ||||||||
MIRT702952 | HIP1 | huntingtin interacting protein 1 | 2 | 2 | ||||||||
MIRT706016 | ZSCAN2 | zinc finger and SCAN domain containing 2 | 2 | 2 | ||||||||
MIRT706032 | F2R | coagulation factor II thrombin receptor | 2 | 2 | ||||||||
MIRT706135 | MTRNR2L10 | MT-RNR2-like 10 | 2 | 2 | ||||||||
MIRT706394 | HAS2 | hyaluronan synthase 2 | 2 | 2 | ||||||||
MIRT713293 | DCP2 | decapping mRNA 2 | 2 | 2 | ||||||||
MIRT716583 | BRAP | BRCA1 associated protein | 2 | 2 | ||||||||
MIRT720433 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|